Company logo

MASI - Masimo Corporation

NASDAQ -> Healthcare -> Medical Instruments & Supplies
Irvine, United States
Type: Equity

MASI price evolution
MASI
(in millions $) 28 Oct 2024 30 Jun 2024 31 Mar 2024 31 Dec 2023
Current assets
Cash $129.6 $157.6 $163
Short term investments
Net receivables $444.6 $337.7 $330.7 $355.5
Inventory $569.9 $513 $506.1 $545
Total current assets $1279.9 $1142.2 $1165.6 $1231.9
Long term investments $66.5 $70.3 $71.4
Property, plant & equipment $501 $413.9 $415 $424.4
Goodwill & intangible assets $995.1 $1031.9 $1060
Total noncurrent assets $1751.7 $1792.1 $1809.6
Total investments $66.5 $70.3 $71.4
Total assets $3087.8 $2893.9 $2957.7 $3041.5
Current liabilities
Accounts payable $280.8 $216 $203.1 $251.5
Deferred revenue $79.8 $70 $87.3
Short long term debt
Total current liabilities $637.6 $546.2 $504.2 $563.8
Long term debt $733.2 $746.5 $841.4 $871.7
Total noncurrent liabilities $978.9 $1088.3 $1112.9
Total debt $746.5 $841.4 $871.7
Total liabilities $1624.6 $1525.1 $1592.5 $1676.7
Shareholders' equity
Retained earnings $1840.5 $1830.7 $1814.7 $1795.8
Other shareholder equity -$36.6 -$103.4 -$75.3 -$45.3
Total shareholder equity $1368.8 $1365.2 $1364.8
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $163 $202.9 $745.25 $641.45
Short term investments
Net receivables $355.5 $505.1 $200.76 $141.35
Inventory $545 $501 $201.37 $215.95
Total current assets $1231.9 $1308.6 $1238.41 $1101.16
Long term investments $71.4 $73.1 $73.69 $57.67
Property, plant & equipment $424.4 $472.1 $272.79 $272.51
Goodwill & intangible assets $1060 $1168 $172.84 $177.13
Total noncurrent assets $1809.6 $1902 $648.6 $611.39
Total investments $71.4 $73.1 $73.69 $57.67
Total assets $3041.5 $3210.6 $1887.01 $1712.55
Current liabilities
Accounts payable $251.5 $276.8 $75.63 $64.06
Deferred revenue $87.3 $80.6 $50.88 $44.94
Short long term debt
Total current liabilities $563.8 $630 $267.74 $233.84
Long term debt $871.7 $941.6
Total noncurrent liabilities $1112.9 $1241.7 $69.03 $71.08
Total debt $871.7 $941.6 $34.35
Total liabilities $1676.7 $1871.7 $336.76 $304.91
Shareholders' equity
Retained earnings $1795.8 $1714.3 $1570.86 $1341.23
Other shareholder equity -$45.3 $11.5 -$5.53 $1.41
Total shareholder equity $1364.8 $1338.9 $1550.24 $1407.66
(in millions $) 30 Oct 2024 30 Jun 2024 31 Mar 2024 31 Dec 2023
Revenue
Total revenue $496.3 $492.8 $548.9
Cost of revenue $241.5 $251.1 $286.2
Gross Profit $254.8 $241.7 $262.7
Operating activities
Research & development $49 $47.8 $38
Selling, general & administrative $177.5 $159.9 $159.9
Total operating expenses $226.5 $207.7 $218.7
Operating income $28.3 $34 $44
Income from continuing operations
EBIT $19.9 $24.9 $23.1
Income tax expense $3.9 $6 -$10.8
Interest expense
Net income
Net income $16 $18.9 $33.9
Income (for common shares) $16 $18.9 $33.9
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $2048.1 $2035.8 $1239.15 $1143.74
Cost of revenue $1044.6 $977 $430.81 $400.68
Gross Profit $1003.5 $1058.8 $808.35 $743.07
Operating activities
Research & development $175.2 $191.4 $137.23 $118.66
Selling, general & administrative $664 $657.4 $395.29 $369.06
Total operating expenses $867 $848.8 $532.52 $487.24
Operating income $136.5 $210 $275.82 $255.82
Income from continuing operations
EBIT $88.1 $193.4 $274.38 $263.76
Income tax expense $6.6 $49.9 $44.73 $23.45
Interest expense
Net income
Net income $81.5 $143.5 $229.65 $240.3
Income (for common shares) $81.5 $143.5 $229.65 $240.3
(in millions $) 28 Oct 2024 30 Jun 2024 31 Mar 2024 31 Dec 2023
Net income $16 $18.9 $33.9
Operating activities
Depreciation $23.9 $24.3 $22.5
Business acquisitions & disposals
Stock-based compensation $13.5 $9.6 $9.4
Total cash flows from operations $74.5 $45.8 $77.1
Investing activities
Capital expenditures $3.2 -$8.2 -$10.9
Investments
Total cash flows from investing -$34.7 -$2.3 -$18.9 -$25.3
Financing activities
Dividends paid
Sale and purchase of stock $2.8 $7.1 $0.3
Net borrowings -$93.3 -$28.3 -$36.4
Total cash flows from financing -$119.1 -$91 -$26.5 -$36.3
Effect of exchange rate $3.4 -$9.6 -$4.6 $20.4
Change in cash and equivalents -$4.5 -$28.4 -$4.2 $35.9
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income $81.5 $143.5 $229.65 $240.3
Operating activities
Depreciation $98.3 $136.1 $35.62 $29.3
Business acquisitions & disposals $7.5 -$999.7 -$116.08
Stock-based compensation $7 $47.7 $44.62 $42.23
Total cash flows from operations $94.1 $29.4 $264.75 $210.96
Investing activities
Capital expenditures -$44 -$52.8 -$25.5 -$72.55
Investments $120
Total cash flows from investing -$81.2 -$1057.7 -$37.53 -$82.79
Financing activities
Dividends paid
Sale and purchase of stock $7 -$393.4 -$105.68 -$52.12
Net borrowings -$51.2 $939.2
Total cash flows from financing -$57.1 $520.4 -$122.4 -$54.31
Effect of exchange rate $2.8 -$30.9 -$1.45 $3.06
Change in cash and equivalents -$41.4 -$538.8 $103.37 $76.93
Fundamentals
Market cap $8.90B
Enterprise value N/A
Shares outstanding 53.50M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA N/A
ROE N/A
Debt/Equity 1.23
Net debt/EBITDA N/A
Current ratio 2.01
Quick ratio 1.11